Clinical Trials
All Clinical Trials - Page 10 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT07041983N/AEnrolling By Invitation
24-h Energy Expenditure and Anti-obesity Medication
Tirzepatide
- NCT07030621Phase 3Not Yet Recruiting
Efficacy of Semaglutide in Improving Neurological Outcomes After Endovascular Thrombectomy for Acute Ischemic Stroke: A Randomized Double-Blind Controlled Trial
Semaglutide
- NCT06937749Phase 2Recruiting
A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Mazdutide
- NCT07012837Phase 3Not Yet Recruiting
Transfusion Reduction in High-Bleeding-Risk Cardiac Surgery With Desmopressin
Desmopressin
- NCT06934642EARLY_Phase 1Recruiting
Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
Tirzepatide
- NCT06937099Phase 3Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Tirzepatide
- NCT06937086Phase 3Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Tirzepatide
- NCT06973304Phase 3Active Not Recruiting
A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
Teduglutide
- NCT07037459Phase 3Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Maridebart-Cafraglutide
- NCT07101939Phase 2Recruiting
A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)
Semaglutide
- NCT06924697N/AEnrolling By Invitation
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
Semaglutide
- NCT07239570Phase 4Recruiting
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
Semaglutide
- NCT06852391Phase 4Recruiting
JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
Semaglutide
- NCT07000955Phase 1/Phase 2Active Not Recruiting
Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity
Tirzepatide
- NCT07225829Phase 2Active Not Recruiting
A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
Liraglutide
- NCT06987695Phase 3Active Not Recruiting
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants in Japan Who Have Obesity Disease
Maridebart-Cafraglutide
- NCT06967389N/ARecruiting
Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
Semaglutide
- NCT07010432Phase 1Recruiting
The Role of the Amylin Analogue Cagrilintide in Bone Metabolism
Semaglutide
- NCT06931028Phase 3Recruiting
A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2
Mazdutide
- NCT06878664Phase 3Recruiting
Randomized Interval Assessment Trial of Lu177-Dotatate in Slowly Progressive G1-2 Advanced Midgut Neuroendocrine Tumors
Octreotide
- NCT06989177N/ARecruiting
Probiotic Intervention on Body Weight
Semaglutide
- NCT06989203N/ARecruiting
Protein Supplementation Intervention on Body Weight
Semaglutide
- NCT07015268Phase 3Active Not Recruiting
A Clinical Study of KLH-2109 in Patients With Endometriosis
Gonadorelin
- NCT06865677Phase 2Terminated
Sacituzumab Govitecan for Relapsed Ovarian, Endometrial, and Cervical Carcinomas
Octreotide
- NCT06337838Phase 3Recruiting
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
Desmopressin
- NCT06982846Phase 1Completed
A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
Retatrutide
- NCT07011667Phase 3Active Not Recruiting
A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term
Semaglutide
- NCT06982859Phase 1Active Not Recruiting
A Study to Evaluate the Effect of Retatrutide on Insulin Secretion and Insulin Sensitivity in Adult Participants With Type 2 Diabetes Mellitus
Retatrutide
- NCT07293325N/ARecruiting
Semaglutide and Tirzepatide for Genetic Aging Delay in Adults With Obesity
Tirzepatide
- NCT06639464Phase 2Recruiting
Semaglutide for Helping Opioid Recovery
Semaglutide
- NCT07610174Phase 2Completed
Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves
Semaglutide
- NCT06946628Phase 3Not Yet Recruiting
New Triple Therapy in Newly Diagnosed Type 2 Diabetes
Semaglutide
- NCT07374328Phase 1/Phase 2Recruiting
Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus
Semaglutide
- NCT06974344Phase 4Not Yet Recruiting
Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial)
Octreotide
- NCT06898060Phase 3Not Yet Recruiting
To Evaluate the Efficacy and Safety of Abaloparatide Injection (QLG2128) in the Treatment of Postmenopausal Women With Osteoporosis and at High Risk of Fracture
Teriparatide
- NCT06784752Phase 3Recruiting
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Octreotide
- NCT07035093Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
Retatrutide
- NCT06851962Phase 4Completed
Impact of Pharmacogenetic-Guided Treatment on Type 2 Diabetes.
Semaglutide
- NCT07094568N/ARecruiting
Tirzepatide vs Liraglutide in Bone
Tirzepatide
- NCT06901349Phase 2Withdrawn
A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes
Tirzepatide
- NCT05974774Phase 3Recruiting
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors
Gonadorelin
- NCT06742710Phase 4Recruiting
Liraglutide Treatment in Obese Infertile PCOS Women
Liraglutide
- NCT06972472Phase 3Active Not Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Type 2 Diabetes
Orforglipron
- NCT06987669N/ANot Yet Recruiting
Gastric Emptying in Healthy Volunteers and GLP-1 Agonist Users
Semaglutide
- NCT06972459Phase 3Active Not Recruiting
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
Orforglipron
- NCT06993792Phase 3Active Not Recruiting
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
Orforglipron
- NCT06976853Phase 2Recruiting
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
Tirzepatide
- NCT06962280Phase 3Active Not Recruiting
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
Tirzepatide
- NCT06497595N/ARecruiting
Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
Semaglutide
- NCT06937203Phase 1/Phase 2Recruiting
A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Tirzepatide